Kiril Domuschiev and Georgi Domuschief

Owners of Huvepharma, one of the largest animal pharmaceutical companies, globally. Number

🤖

AI Overview

With $1.2M in lobbying spend across 19 quarterly filings, Kiril Domuschiev and Georgi Domuschief is a significant lobbying presence. Their lobbying covers 3 issue areas. Active from 2024 to 2025.

$1.2M

Total Spend

Years Active

Firms Hired

Lobbyists Deployed

Issues Lobbied

Spending Trend

View as table

Year	Lobbying Spend
2024	$975K
2025	$225K

Issues Lobbied

Government Issues Animals Pharmacy

Lobbying Firms

Washington Global Advisors LLC

Lobbyists

Philip Bay Patrick Hughes (Contractor)Ralph Johnson (Contractor)

Government Agencies Targeted

These are the government entities that Kiril Domuschiev and Georgi Domuschief disclosed contacting in their lobbying filings.

Commerce, Dept of (DOC)State, Dept of (DOS)

View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Government Issues, Animals, Pharmacy

US Government relations in general. Assisting them with problems caused by local adversaries.

The main objective is to highlight the business activities of Kiril & Georgi Domuschiev in the US & Europe. The focus is on Huvepharma, one of the largest animal pharmaceutical companies in the US. Th

Please see previous description